The two companies’ applications for China-approved PD-1 inhibitor camrelizumab and the VEGFR tyrosine kinase inhibitor ...

Following this month's FDA approval of Eli Lilly’s amyloid-busting antibody Kisunla (donanemab), the Alzheimer’s disease ...

The dog days of summer might be in full swing, but for flu vaccine makers, its a busy time prepping for this fall's influenza ...

Freshly equipped with two approved meds from Acorda Therapeutics, Frankfurt, Germany’s Merz Therapeutics is kicking its ...

It’s well known that obesity drugs from Novo Nordisk and Eli Lilly are on a high-flying growth trajectory that doesn’t look ...

In surging to the top spot in the market cap rankings in Europe, Novo Nordisk has been on an extended winning streak. But the ...

After a rocky road to approval and two amendments to the original pact, Akebia Therapeutics and CSL Vifor have terminated ...

AbbVie is asking the U.S. Supreme Court to overrule a lower court’s ruling that the company must turn over records of ...

Ogilvy Health has added to the roster at its Singapore office, hiring Sofia Beccarelli as associate planning director for the ...

CDMO Tergus Pharma plans to merge with MedPharm, a U.K.-based company that specializes in the development of dermatology, ...

Just seven weeks after projecting an 18% revenue boost for this year, Indivior has slashed its estimate to an 8% increase, ...

Johnson & Johnson will pay Emergent BioSolutions $50 million to settle a two-year contract squabble and bring closure to an ...